We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$4.08B
1-Year Est. Return
58.77%
This Fund
S&P 500
This Quarter
Est. Return
+36.08%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+531.4%
AUM
$4.08B
AUM Growth
+$236M
(+6.1%)
Cap. Flow
-$708M
Cap. Flow
% of AUM
-17.33%
Top 10 Holdings %
Top 10 Hldgs %
19.32%
Holding
5,845
New
764
Increased
1,966
Reduced
2,392
Closed
665
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$130M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$81.7M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$44.4M |
| 4 |
iShares 0-3 Month Treasury Bond ETF
SGOV
|
+$38M |
| 5 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$32M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$361M |
| 2 |
Micron Technology
MU
|
+$160M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$136M |
| 4 |
Apple
AAPL
|
+$49.2M |
| 5 |
Tesla
TSLA
|
+$44.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 34.65% |
| 2 | Technology | 23.8% |
| 3 | Financials | 7.62% |
| 4 | Industrials | 7.22% |
| 5 | Healthcare | 6.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SGP
3701
SpyGlass Pharma
SGP
$905M
| $16.7K | ﹤0.01% |
+750
| New | +$16.3K |
|
3702
Invesco Leisure and Entertainment ETF
PEJ
$359M
| $16.6K | ﹤0.01% |
250
-13,402
| -98% | -$832K |
|
3703
Comstock Holding Companies
CHCI
$199M
| $16.6K | ﹤0.01% |
+1,040
| New | +$17.3K |
|
3704
Neumora Therapeutics
NMRA
$127M
| $16.6K | ﹤0.01% |
9,763
+5,695
| +140% | +$10.8K |
|
3705
IBEX
IBEX
$591M
| $16.6K | ﹤0.01% |
546
-436
| -44% | -$13K |
|
3706
Ovid Therapeutics
OVID
$469M
| $16.6K | ﹤0.01% |
+6,164
| New | +$15.9K |
|
|
OSG
3707
Octave Specialty Group
OSG
$189M
| $16.5K | ﹤0.01% |
2,650
-1,499
| -36% | -$7.8K |
|
|
KLC
3708
KinderCare Learning Companies
KLC
$251M
| $16.5K | ﹤0.01% |
3,882
-1,285
| -25% | -$4.74K |
|
|
VSNT
3709
Versant Media Group
VSNT
$4.56B
| $16.5K | ﹤0.01% |
458
-7,155
| -94% | -$287K |
|
|
EEX
3710
DELISTED
Emerald Holding
EEX
| $16.5K | ﹤0.01% |
3,270
-3,966
| -55% | -$19.3K |
|
3711
Nu Holdings
NU
$65.6B
| $16.5K | ﹤0.01% |
1,232
-2,185
| -64% | -$29.5K |
|
3712
Afya
AFYA
$1.15B
| $16.5K | ﹤0.01% |
+1,109
| New | +$16.1K |
|
|
AIRO
3713
AIRO Group Holdings
AIRO
$228M
| $16.4K | ﹤0.01% |
2,226
-2,362
| -51% | -$18.5K |
|
|
MAGN
3714
Magnera Corp
MAGN
$432M
| $16.4K | ﹤0.01% |
1,399
-243
| -15% | -$2.66K |
|
3715
Compass Therapeutics
CMPX
$203M
| $16.4K | ﹤0.01% |
7,474
-15,778
| -68% | -$46.6K |
|
|
AYA
3716
Aya Gold & Silver Inc
AYA
$4.1B
| $16.3K | ﹤0.01% |
+862
| New | +$16.3K |
|
3717
Zoom
ZM
$26.2B
| $16.3K | ﹤0.01% |
189
-33
| -15% | -$3.12K |
|
3718
MediWound
MDWD
$179M
| $16.3K | ﹤0.01% |
1,109
-696
| -39% | -$11.1K |
|
|
APC
3719
ARKO Petroleum
APC
$772M
| $16.3K | ﹤0.01% |
+864
| New | +$16.6K |
|
3720
Gyre Therapeutics
GYRE
$779M
| $16.3K | ﹤0.01% |
2,469
-3,294
| -57% | -$22.4K |
|
3721
VinFast Auto
VFS
$7.44B
| $16.3K | ﹤0.01% |
+5,211
| New | +$19.6K |
|
|
FTH
3722
Faeth Therapeutics
FTH
$724M
| $16.3K | ﹤0.01% |
650
-846
| -57% | -$19.6K |
|
3723
Context Therapeutics
CNTX
$31.8M
| $16.2K | ﹤0.01% |
29,331
+28,099
| +2,281% | +$57K |
|
|
RJET
3724
Republic Airways Holdings
RJET
$876M
| $16.2K | ﹤0.01% |
773
+772
| +77,200% | +$15.1K |
|
|
PTNM
3725
DELISTED
Pitanium Ltd
PTNM
| $16.2K | ﹤0.01% |
1,562
| – | – |
|
Similar funds
AA
PL
DWP
GCL
PI
BHC
RSWM
HCM
Tower Research Capital (TRC)'s Q2 2026 Portfolio in Review
As of Q2 2026, Tower Research Capital (TRC) held 5,845 positions worth $4.08B, up 6.1% from $3.85B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Tower Research Capital (TRC) withdrew a net $708M in Q2 2026, closing 665 positions and reducing 2,392 holdings. Its most notable exit was iShares MSCI USA Min Vol Factor ETF, an estimated $13M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 29% a quarter earlier, followed by Technology and Financials.
Against the trend, Tower Research Capital (TRC) opened a new position in iShares Core S&P 500 ETF worth $84M.
- Tower Research Capital (TRC)'s largest Q2 2026 buy was iShares Core S&P 500 ETF: 112,156 shares worth $84M.
- Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $130M increase.
- Tower Research Capital (TRC)'s biggest Q2 2026 reduction was Direxion Daily Semiconductor Bull 3X ETF, cutting an estimated $361M.
- Tower Research Capital (TRC) fully exited iShares MSCI USA Min Vol Factor ETF in Q2 2026, selling an estimated $13M.
- Tower Research Capital (TRC)'s ten largest holdings make up 19% of its $4.08B portfolio in Q2 2026.
- Tower Research Capital (TRC) opened 764 new positions and closed 665 in Q2 2026.
- Tower Research Capital (TRC)'s portfolio value rose 6.1% quarter-over-quarter to $4.08B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.